Selected article for: "acute pandemic and lung disease"
Author: Quaglino, P.; Fava, P.; Brizio, M.; Marra, E.; Rubatto, M.; Agostini, A.; Tonella, L.; Ribero, S.; Fierro, M. T.
Title: Metastatic melanoma treatment with checkpoint inhibitors in the COVID‐19 era: experience from an Italian Skin Cancer Unit
  • Cord-id: 2gjb0usv
  • Document date: 2020_6_4
    • ID: 2gjb0usv
    Snippet: Melanoma epidemiology has shown a constant increase in the last few decades even if mortality is low and only a small percentage of patients develop metastatic disease. For these patients, immunotherapy with checkpoint inhibitors (ICI) significantly improves disease outcome with a median survival more than 2 years. The same drugs are used as adjuvant treatment in disease-free patients. Coronavirus Disease-19 (COVID-19) is now a pandemic disease with lung manifestations, which can bring severe ac
    Document: Melanoma epidemiology has shown a constant increase in the last few decades even if mortality is low and only a small percentage of patients develop metastatic disease. For these patients, immunotherapy with checkpoint inhibitors (ICI) significantly improves disease outcome with a median survival more than 2 years. The same drugs are used as adjuvant treatment in disease-free patients. Coronavirus Disease-19 (COVID-19) is now a pandemic disease with lung manifestations, which can bring severe acute respiratory distress. The most important risk factors related to a higher death risk for COVID-19 pneumonia are elderly age and comorbidities (hypertension, diabetes, previous cancer).

    Search related documents:
    Co phrase search for related documents
    • acute respiratory distress and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress and lung cancer patient: 1
    • acute respiratory distress and lung manifestation: 1, 2, 3, 4, 5, 6
    • acute respiratory distress and lung toxicity: 1, 2
    • adjuvant treatment and lung cancer: 1, 2, 3, 4, 5, 6
    • adjuvant treatment patient and lung cancer: 1